Résultats de la recherche
10
Tout
Rechercher les filtres
Mot-clé
biotech
aTyr Pharma Announces the Appointment of Dalia R. Rayes as Head of Commercial, Global Efzofitimod Franchise
26 mars 2025 08h00 HE
|
aTyr Pharma, Inc.
aTyr Pharma Announces the Appointment of Dalia R. Rayes as Head of Commercial, Global Efzofitimod Franchise
Rakovina Therapeutics Unveils Preclinical Data at the AACR - World’s Premier Cancer Research Forum
25 mars 2025 16h00 HE
|
Rakovina Therapeutics Inc
VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through...
Helicore Biopharma Announces First Participant Dosed in Phase 1 Clinical Trial of HCR-188, a First-in-Class GIP Antagonist for the Treatment of Obesity
25 mars 2025 09h00 HE
|
Helicore Biopharma
Helicore Biopharma Announces First Participant Dosed in Phase 1 Clinical Trial of HCR-188, a First-in-Class GIP Antagonist for the Treatment of Obesity
Genelux Announces Alignment with FDA on Key Elements of the Approval Pathway for Olvi-Vec in Platinum Resistant/Refractory Disease
25 mars 2025 08h30 HE
|
Genelux Corporation
- U.S. Food and Drug Administration states that data from the ongoing OnPrime/GOG-3076 Phase 3 registrational trial could potentially support traditional approval - WESTLAKE VILLAGE, Calif., March ...
Alumis and Kaken Pharmaceutical Announce Collaboration and Licensing Agreement for ESK-001 in Dermatology in Japan
25 mars 2025 02h30 HE
|
Alumis Inc.
Alumis and Kaken Pharmaceutical collaborate for oral next-generation TYK2 inhibitor ESK-001 in dermatology in Japan
Cannara Biotech annonce la nomination de Justin Cohen au conseil d’administration
24 mars 2025 08h30 HE
|
Cannara Biotech (Québec) Inc.
MONTRÉAL, 24 mars 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », la « Société », « nous » ou « notre ») (TSXV : LOVE) (OTCQB : LOVFF) (FRA : 8CB0), producteur verticalement intégré...
Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors
24 mars 2025 08h30 HE
|
Cannara Biotech (Québec) Inc.
Cannara Biotech appoints Justin Cohen to its Board of Directors, enhancing brand strategy with his extensive marketing and digital transformation expertise
Abivax Announces Full Year 2024 Financial Results
24 mars 2025 03h30 HE
|
Abivax
Abivax Announces Full Year 2024 Financial Results • Cash balance of EUR 144.2M as of December 31, 2024; cash runway into Q4 2025 Full enrollment in Phase 3 ABTECT trial evaluating obefazimod...
Silexion Therapeutics Announces Completion of Innovative Expanded Development Plan for SIL204 which will be unveiled at the 2025 NeauxCancer Conference
21 mars 2025 08h30 HE
|
Silexion Therapeutics Corp
Grand Cayman, Cayman Islands, March 21, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi)...
Teclison, Inc. to Participate in Upcoming Investor Conference
20 mars 2025 14h20 HE
|
Teclison
Teclison will present in the MedInvest Biotech + Pharma Investor Conference March 27, 2025 at 2:05pm ET